U.S. Medical Equipment Stock News

Analog Devices (ADI) has drawn fresh attention after quarterly results slightly exceeded expectations. The performance was supported by lean channel inventories and growing design wins in AI, automation, and next generation connectivity, alongside a series of analyst rating upgrades. See our latest analysis for Analog Devices. Those quarterly results and analyst upgrades have landed as the share price trades near record levels around $300.25, with a 30 day share price return of 9.21% and a 90...

In 2025, Clearway Energy Group announced three new long-term PPAs with Google totaling 1.17 GW of carbon-free energy projects across Missouri, Texas, and West Virginia, representing over US$2.40 billion of investment and expected to begin coming online in 2027 and 2028. This deal lifts the Clearway–Google partnership to 1.24 GW, underscoring how hyperscale data center demand is increasingly shaping large-scale clean energy buildouts and local economic benefits. We will now examine how this...

Birkenstock Holding (BIRK) is back in focus after management cut its fiscal 2026 revenue growth target to a range of 13% to 15%, a guidance reset that coincided with a pullback in the stock. See our latest analysis for Birkenstock Holding. The revised outlook has come alongside weaker short term share price momentum, with a 7 day share price return of 11.48% and a 30 day share price return of 17.09%. This has contributed to a 1 year total shareholder return of 35.81%, which suggests sentiment...

If you are wondering whether Hewlett Packard Enterprise (HPE) is priced attractively or asking too much for its future, you are in the right place to get a clear view of what the current share price may be implying. HPE shares last closed at US$21.44, after a 3.3% decline over the past week, a 10.7% decline over the past month, and an 11.3% decline year to date. Over longer periods, the stock shows a 46.2% return over three years and a 104.7% return over five years. These moves sit against a...

If you are wondering whether Pediatrix Medical Group at around US$21.86 is still offering value after its recent run, this review is designed to help you make sense of the current price. The stock has posted a 57.9% return over the last year, even though the 7 day and 30 day returns of 2.1% and 3.1% declines suggest some short term cooling after that move, with a 2.7% gain year to date and a 43.8% return over 3 years against a 10.3% decline over 5 years. Recent coverage of Pediatrix Medical...

If you are wondering whether CRH at around US$122.97 is offering fair value or a potential mispricing, this article walks through what the current numbers actually say about the stock. The share price performance is mixed in the short term, with a 6.4% decline over the last week and roughly flat returns of 0.1% over 30 days. In contrast, the 1 year return of 27.2% and 3 year return of 196.9% set a very different context for longer term holders. Recent coverage around CRH has focused on its...

In early January 2026, the New York Stock Exchange, part of Intercontinental Exchange, announced it would become the U.S. options listings venue for key MSCI benchmark indexes, with contracts to be listed on NYSE Arca and NYSE American options markets pending regulatory approval. This move deepens ICE’s long-running partnership with MSCI and extends its role in index-linked derivatives, building on its already very large share of global MSCI futures trading volumes and benchmark...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Roper Technologies (ROP) is back in focus after Mar Vista Investment Partners chose to exit its long held position, citing slower organic growth compared with software peers and concerns about market saturation. See our latest analysis for Roper Technologies. The recent decision by Mar Vista to exit, alongside reduced but still supportive analyst coverage, has coincided with softer momentum. The 90 day share price return shows a decline of 17.52%, and the 1 year total shareholder return...

Firefly Aerospace (FLY) is back in focus after detailing its Alpha Block II rocket upgrade and preparing the Alpha Flight 7 mission, a testbed for new subsystems that could shape future commercial and national security launch opportunities. See our latest analysis for Firefly Aerospace. The news around Alpha Block II and the upcoming Flight 7 launch is landing at a time when momentum in Firefly Aerospace’s share price return has picked up, with a 1 day share price return of 12.30% and a 30...

Why Nvidia’s CES spotlight on Serve Robotics matters for investors Nvidia CEO Jensen Huang’s CES spotlight on Serve Robotics (SERV) as a physical AI leader, with a large U.S. sidewalk delivery robot fleet and a DoorDash partnership, has pushed the stock firmly back onto investor radars. See our latest analysis for Serve Robotics. The CES spotlight comes after a sharp recent move in Serve Robotics, with a 1 month share price return of 55.34% and a year to date share price return of 25.40%...

Cooper Companies (COO) has drawn fresh attention after CooperVision announced the forthcoming launch of MyDay MiSight 1 day contact lenses across the UK and selected European markets, targeting childhood myopia management. See our latest analysis for Cooper Companies. Despite the product launch, Cooper Companies’ recent share price performance has been mixed, with a 14.45% 90 day share price return contrasting with an 11.69% decline in 1 year total shareholder return. This suggests short term...

If you are wondering whether Alnylam Pharmaceuticals' current share price lines up with its underlying value, this article will walk through what the numbers are really saying. The stock last closed at US$359.27, with a 1 year return of 45.9% and a 5 year return of 108.4%. Over shorter periods, the share price has seen a 7 day return of a 9.8% decline and a 30 day return of a 9.3% decline, with a year to date return of a 10.2% decline. Recent news around Alnylam has focused on its RNA...

If you are wondering whether Sterling Infrastructure's share price still makes sense after its strong run, you are not alone. The stock last closed at US$350.96, with returns of 13.9% over 7 days, 23.8% over 30 days, 10.0% year to date and 92.3% over the past year, while the 3 year and 5 year returns are very large. The recent price action has drawn fresh attention to the company as investors reassess what they are willing to pay for its future prospects. While there has not been a single...

Recent performance snapshot Aon (AON) has been relatively steady lately, with the stock closing at $343.86 and showing modest negative returns over the past week, month, and past 3 months, which may catch the attention of value-focused investors. See our latest analysis for Aon. Zooming out, Aon’s 1 year total shareholder return of a 5.32% decline contrasts with a 73.26% gain over 5 years, while recent share price returns suggest momentum has softened rather than accelerated. If you are...

BRC Group Holdings (RILY) is back in focus after reporting third quarter 2025 earnings that shifted from a net loss a year ago to substantial net income, along with lower net debt and restored Nasdaq compliance. See our latest analysis for BRC Group Holdings. That earnings swing and return to Nasdaq compliance have gone hand in hand with sharp share price moves, including a 98% 1 month share price return and a 71.62% year to date share price return, even as the 3 year total shareholder return...

If you are wondering whether TPG at around US$67 per share is priced attractively or already baking in a lot of optimism, you are in the right place. The stock has recent returns of 0.5% over 7 days, 3.3% over 30 days, 2.1% year to date and 3.6% over 1 year, with a very large 3 year return of 131.3%. This naturally raises questions about how much value is left on the table. Investors have been paying close attention to TPG as interest in listed alternative asset managers has grown, with...

In recent days, FormFactor, a provider of semiconductor test and measurement technologies, has drawn fresh attention as sector-wide enthusiasm for AI-related chip demand and expectations for its upcoming February 4, 2026 earnings release have sharpened focus on its role in testing advanced components such as High-Bandwidth Memory wafers. Alongside this renewed interest, a pattern of insider share sales and increasingly optimistic analyst sentiment on AI-driven testing demand is prompting...

Unfortunately for some shareholders, the Oriental Rise Holdings Limited ( NASDAQ:ORIS ) share price has dived 27% in...

Casey's General Stores (CASY) has drawn attention after outlining plans to expand its goodstop sub brand in Iowa, while also preparing to present at the ICR Conference 2026 in Orlando. See our latest analysis for Casey's General Stores. The recent goodstop expansion news comes on the back of strong market interest, with Casey's 30-day share price return of 15.45% and 1-year total shareholder return of 64.31% pointing to building momentum rather than fading enthusiasm. If you are looking...

Albertsons Companies (ACI) has been in focus after its third quarter earnings, updated 2025 sales outlook, and a reaffirmed quarterly dividend, all released as management and analysts addressed consumer pressure and competition. See our latest analysis for Albertsons Companies. At a share price of US$17.32, Albertsons has seen short term momentum soften, with a 90 day share price return of 12.26% and a 1 year total shareholder return of 9.17%, although the 5 year total shareholder return of...

Short term moves and recent performance snapshot Peloton Interactive (PTON) has seen mixed recent returns, with the share price down about 5.5% over the past day and 7.5% over the past week, while showing a small gain over the past month. Over the past 3 months, the stock is down roughly 15.6%, and the past year shows a total return decline of about 23.5%. This sets the context for how investors may be reassessing the story today. See our latest analysis for Peloton Interactive. At a share...

Analyst upgrade puts Fabrinet (FN) back in focus Barclays’ decision to upgrade Fabrinet (FN) and lift its outlook has put fresh attention on the stock, as broader analyst sentiment has turned more positive around the company’s potential and execution. See our latest analysis for Fabrinet. Fabrinet’s share price has moved to US$494.45, with a 7 day share price return of 10.56% and a 90 day share price return of 20.63%. Its 1 year total shareholder return of 104.41% and 5 year total shareholder...

EnerSys recently reported a past quarter in which revenue rose 7.6% year on year and exceeded analyst estimates by 6.9%, while also issuing earnings-per-share guidance above forecasts. The company attributed this outperformance to solid execution and continuous improvement initiatives, underlining how operational discipline is shaping its financial profile. We’ll now examine how EnerSys’ stronger-than-expected quarterly results and above-consensus EPS guidance interact with and potentially...